Alerts will be sent to your verified email
Verify EmailGANGAPHARM
Ganga Pharma.
|
Kobo Biotech
|
Fabino Enterprises
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
1.2 % | -1.77 % | 0.76 % |
5yr average Equity Multiplier
|
1.4 | 4.06 | 2.01 |
5yr Average Asset Turnover Ratio
|
0.33 | 0.54 | 0.98 |
5yr Avg Net Profit Margin
|
2.35 % | -3.79 % | 0.54 % |
Price to Book
|
0.0 | 0.0 | 0.0 |
P/E
|
82.59 | 0.0 | 106.03 |
5yr Avg Cash Conversion Cycle
|
183.46 Days | 0.0 | 59.85 Days |
Inventory Days
|
158.14 Days | 89.28 Days | 81.8 Days |
Days Receivable
|
120.91 Days | 0.0 | 131.05 Days |
Days Payable
|
141.14 Days | 147.48 Days | 60.4 Days |
5yr Average Interest Coverage Ratio
|
1.42 | 0.99 | 5.69 |
5yr Avg ROCE
|
4.7 % | 11.79 % | 1.29 % |
5yr Avg Operating Profit Margin
|
3.58 % | 8.83 % | 1.24 % |
5 yr average Debt to Equity
|
0.3 | 1.62 | 0.14 |
5yr CAGR Net Profit
|
-23.43 % | n/a | -4.36 % |
5yr Average Return on Assets
|
0.85 % | -0.89 % | 0.49 % |
Shareholdings
|
|||
Promoter Holding
|
56.02 % | 44.95 % | 56.82 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
-10.69 % | 0.0 | 0.0 |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
Ganga Pharma.
|
Kobo Biotech
|
Fabino Enterprises
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|